Formulation

Each delayed-release capsule contains:
Omeprazole (as enteric-coated pellets)	40 mg

Omeprazole

Omepron® 40 mg Capsule

Prescription Drug

Indication

For the short-term and maintenance treatment of the following conditions:
- Duodenal ulcer
- Gastric ulcer
- Pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine adenomas, and systemic mastocytis)
- Gastroesophageal Reflux Disease (GERD) and other symptoms associated with the disease
- NSAID-associated gastric and duodenal ulcers or erosions
- Acid-related dyspepsia
- Erosive Esophagitis
- Helicobacter pylori eradication regimens in peptic ulcer disease

• Prophylaxis of acid aspiration during general anesthesia

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Download Product Insert

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.